0.2 μg/μL in TE for sensitive chromatographic and analytical workflows requiring minimal baseline interference.
🌡
Storage & shipping
Store at -20°C Ships Ice chest + Ice pads Check lot-specific COA for exact specifications.
📋
Quality documents
SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.
📚
Literature proof
Cited in 0 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.
Overview
The Lenti-luciferase-P2A-Neo plasmid is a lentiviral vector designed for gene expression studies, particularly in mammalian cells, using luciferase as a reporter gene. The plasmid includes a P2A self-cleaving peptide and Neomycin resistance gene (Neo), which allow for both the expression of luciferase and the selection of successfully transduced cells. The lentiviral backbone ensures stable integration into the host genome, making it useful for long-term studies. A TFIID-SAGA Perturbation that Targets MYB and Suppresses Acute Myeloid Leukemia. Product Specifications Concentration: 0.2 μg/μL in TE Volume: 50 μL Backbone size: 8833 bp Vector type: Cloning vector Promoter: EF-1α Bacterial Resistance(s): Ampicillin Copy number: High Copy
Specifications
Specifications & Purity
0.2 μg/μL in TE
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
This product requires cold chain shipping. Ground and other economy services are not available.
Documentation
📋 Safety Data Sheet (SDS)
Comprehensive hazard, handling, storage, and regulatory compliance document.
We use cookies to ensure the website functions properly and, where permitted, to improve your experience. You can manage your preferences at any time in Settings. Learn more in our Cookie Policy.
Shall we send you a message when we have discounts available?
Remind me later
Thank you! Please check your email inbox to confirm.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.